Your browser doesn't support javascript.
loading
Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab.
Maeda, Yuka; Wada, Hisashi; Sugiyama, Daisuke; Saito, Takuro; Irie, Takuma; Itahashi, Kota; Minoura, Kodai; Suzuki, Susumu; Kojima, Takashi; Kakimi, Kazuhiro; Nakajima, Jun; Funakoshi, Takeru; Iida, Shinsuke; Oka, Mikio; Shimamura, Teppei; Doi, Toshihiko; Doki, Yuichiro; Nakayama, Eiichi; Ueda, Ryuzo; Nishikawa, Hiroyoshi.
Afiliación
  • Maeda Y; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, 104-0045/Chiba, 277-8577, Japan.
  • Wada H; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan. hwada@gesurg.med.osaka-u.ac.jp.
  • Sugiyama D; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
  • Saito T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
  • Irie T; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, 104-0045/Chiba, 277-8577, Japan.
  • Itahashi K; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, 104-0045/Chiba, 277-8577, Japan.
  • Minoura K; Department of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
  • Suzuki S; Department of Tumor Immunology, Aichi Medical University, Aichi, 480-1195, Japan.
  • Kojima T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
  • Kakimi K; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.
  • Nakajima J; Department of Thoracic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
  • Funakoshi T; Department of Dermatology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, 467-8601, Japan.
  • Oka M; Department of Respiratory Medicine, Kawasaki Medical School, Okayama 701-0192, Japan.
  • Shimamura T; Department of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
  • Doi T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
  • Doki Y; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
  • Nakayama E; Faculty of Health and Welfare, Kawasaki University of Medical Welfare, Okayama, 701-0192, Japan.
  • Ueda R; Department of Tumor Immunology, Aichi Medical University, Aichi, 480-1195, Japan. uedaryu@aichi-med-u.ac.jp.
  • Nishikawa H; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, 104-0045/Chiba, 277-8577, Japan. hnisihika@ncc.go.jp.
Nat Commun ; 12(1): 7280, 2021 12 14.
Article en En | MEDLINE | ID: mdl-34907192
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Anticuerpos Monoclonales Humanizados / Células T de Memoria / Antineoplásicos Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Anticuerpos Monoclonales Humanizados / Células T de Memoria / Antineoplásicos Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Japón